WebStrong evidence supports moderate-dose statins as the best therapy in primary prevention for patients at elevated risk, with relative risk reductions in cardiovascular events … Web11 jan. 2024 · Use of Statin Therapy in Moderate Hypertriglyceridemia The second recommendation (class IIa) is targeted at adults age 40-75 with moderate or severe hypertriglyceridemia >500mg/dL (5.6mmol/L) with an ASCVD risk of 7.5% or higher for whom the above factors have been addressed.
The Use of Statins in Pediatrics: Knowledge Base, Limitations, and ...
WebAFP's Top 20 Articles, 2024, 2024, 2024 Web10 mrt. 2024 · Based on a review of the evidence, the task force recommends that clinicians prescribe statins for the primary prevention of CVD for adults who are ages 40 to 75; … edge of glory saxophone
Statin Safety and Adverse Events - American College of …
WebFor patients in this high-risk group, statins are a therapeutic option to achieve a low LDL cholesterol level (i.e., lower than 70 mg per dL [1.8 mmol per L]). 7 This … Web25 jan. 2024 · d. For individuals aged >75 years, total PSA <4 ng/ml and DRE normal (if done) and no other indications for biopsy: Repeat screening in select patients (very healthy individuals with little or no comorbidity) at 1-4 year intervals e. For individuals aged >75 years, total PSA >4 ng/ml or very suspicious DRE: Any one of the following Web2 feb. 2024 · Statin therapy produces significant reductions in major vascular events irrespective of age, but there is less direct evidence of benefit among patients older than 75 years who do not already have evidence of occlusive vascular disease. This limitation is now being addressed by further trials. Funding congressional hearing epa